INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 155 filers reported holding INARI MED INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $14,465,368 | -2.4% | 300,423 | -2.7% | 0.01% | 0.0% |
| Q1 2024 | $14,815,361 | -59.8% | 308,782 | -45.6% | 0.01% | -60.9% |
| Q4 2023 | $36,826,911 | +22.5% | 567,266 | +23.4% | 0.02% | +4.5% |
| Q3 2023 | $30,060,719 | +155.7% | 459,644 | +127.3% | 0.02% | +175.0% |
| Q2 2023 | $11,754,804 | -4.4% | 202,181 | +1.6% | 0.01% | -11.1% |
| Q1 2023 | $12,289,471 | -2.5% | 199,052 | +0.4% | 0.01% | 0.0% |
| Q4 2022 | $12,599,498 | -14.6% | 198,230 | -2.3% | 0.01% | -25.0% |
| Q3 2022 | $14,745,000 | -46.8% | 202,998 | -50.2% | 0.01% | -42.9% |
| Q2 2022 | $27,732,000 | -4.9% | 407,884 | +26.8% | 0.02% | +16.7% |
| Q1 2022 | $29,156,000 | +5359.9% | 321,662 | +5394.7% | 0.02% | – |
| Q4 2021 | $534,000 | -7.8% | 5,854 | -18.0% | 0.00% | – |
| Q3 2021 | $579,000 | +14.2% | 7,135 | +31.3% | 0.00% | – |
| Q2 2021 | $507,000 | -66.4% | 5,434 | -61.5% | 0.00% | -100.0% |
| Q1 2021 | $1,511,000 | +72.7% | 14,119 | +40.9% | 0.00% | 0.0% |
| Q4 2020 | $875,000 | – | 10,022 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 350,000 | $22,890,000 | 3.17% |
| Prosight Management, LP | 130,000 | $8,502,000 | 2.69% |
| SECTORAL ASSET MANAGEMENT INC | 138,043 | $9,028,012 | 1.76% |
| Berry Street Capital Management LLP | 87,500 | $5,722,500 | 1.68% |
| Millrace Asset Group, Inc. | 17,825 | $1,166 | 1.44% |
| Pier Capital, LLC | 109,185 | $7,140,699 | 1.15% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 104,104 | $6,808,402 | 1.11% |
| Lisanti Capital Growth, LLC | 99,655 | $6,517,437 | 1.03% |
| HAMILTON LANE ADVISORS LLC | 49,800 | $3,256,920 | 0.93% |
| HARBOURVEST PARTNERS LLC | 38,540 | $2,520,516 | 0.86% |